Nobel Award Recognizes Groundbreaking Immune System Discoveries

The prestigious award in medical science has been awarded for revolutionary findings that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—share this accolade.

Their research uncovered unique "sentinels" within the defense system that remove rogue immune cells capable of harming the body.

The findings are now enabling innovative treatments for autoimmune diseases and cancer.

The winners will share a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for understanding how the immune system functions and the reason we don't all develop serious autoimmune diseases," commented the head of the award panel.

The team's research explain a core question: In what way does the defense system protect us from numerous infections while leaving our healthy cells intact?

The immune system employs immune cells that scan for indicators of disease, including viruses and bacteria it has not met before.

Such cells utilize detectors—called recognition units—that are generated randomly in a vast number of variations.

This provides the immune system the capacity to fight a wide array of threats, but the randomness of the mechanism unavoidably produces immune cells that may attack the host.

Security Guards of the Immune System

Researchers previously understood that some of these harmful defense cells were eliminated in the immune organ—the site where white blood cells mature.

This year's Nobel Prize honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which patrol the body to disarm other defenders that assault the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel added, "These findings have laid the foundation for a novel area of research and accelerated the development of new treatments, for example for tumors and immune disorders."

Regarding malignancies, T-regs block the body from fighting the tumor, so studies are aimed at reducing their numbers.

In autoimmune diseases, experiments are exploring increasing regulatory T-cells so the organism is no longer under attack. A similar approach could also be effective in reducing the risks of transplanted organ failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland extracted, leading to autoimmune disease.

He showed that introducing defense cells from other mice could prevent the disease—suggesting there was a system for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in rodents and people that resulted in the discovery of a genetic factor critical for how T-regs operate.

"The pioneering work has uncovered how the body's defenses is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," said a prominent physiology expert.

"This research is a remarkable illustration of how fundamental physiological study can have broad consequences for public health."